Cooper Graham K

Director at BEAM; Chief Financial Officer at Receptos, Inc.; CFO and Treasurer at Orexigen Therapeutics, Inc.

Sold, on record
$5.7M
Dollars the filings state
Form 4 sales
8
Latest Jul 6, 2021
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Nov 20, 2007 2007

    Sold 4,000 shares at $14.74 ($59k)

    Cooper Graham K, CFO and Treasurer

    Sold 100% of holdings ($59k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Dec 20, 2007 +30 days

    Sold 4,000 shares at $14.09 ($56k)

    Cooper Graham K, CFO and Treasurer

    Sold 100% of holdings ($56k position)0 shares leftFiling

  3. 3 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Aug 21, 2008 +245 days

    Sold 8,259 shares at $12.00 ($99k)

    Cooper Graham K, CFO and Treasurer

    Sold 100% of holdings ($99k position)0 shares leftFiling

  4. 4 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Dec 21, 2009 +487 days

    Sold 82,500 shares at $8.22 ($678k)

    Cooper Graham K, CFO and Treasurer

    Sold 82.5% of holdings ($822k position)17,500 shares leftFiling

  5. 5 Form 4 sale Orexigen Therapeutics, Inc.Unusual
    Dec 21, 2009 same day

    Sold 17,500 shares at $8.39 ($147k)

    Cooper Graham K, CFO and Treasurer

    Sold 100% of holdings ($147k position)0 shares leftFiling

  6. 6 Form 4 sale Receptos, Inc.Unusual
    Sep 16, 2014 +1730 days

    Sold 50,000 shares at $61.30 ($3.1M)

    Cooper Graham K, Chief Financial Officer

    Sold 100% of holdings ($3.1M position)0 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale BEAMUnusual
    Jun 28, 2021 +2477 days

    Sold 12,045 shares at $106.34 ($1.3M)

    Cooper Graham K, Director

    Sold 100% of holdings ($1.3M position)0 shares leftFirst sale on recordFiling

  8. 8 Form 4 sale BEAMUnusual
    Jul 6, 2021 +8 days

    Sold 2,614 shares at $120.61 ($315k)

    Cooper Graham K, Director

    Sold 100% of holdings ($315k position)0 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Cooper Graham K
Source
Jul 6, 2021Jul 8, 2021BEAMDirectorForm 4 sale2,614$315k100.0%UnusualSEC
Jun 28, 2021Jun 30, 2021BEAMDirectorForm 4 sale12,045$1.3M100.0%UnusualSEC
Sep 16, 2014Sep 17, 2014Receptos, Inc.Chief Financial OfficerForm 4 sale50,000$3.1M100.0%UnusualSEC
Dec 21, 2009Dec 23, 2009Orexigen Therapeutics, Inc.CFO and TreasurerForm 4 sale17,500$147k100.0%UnusualSEC
Dec 21, 2009Dec 23, 2009Orexigen Therapeutics, Inc.CFO and TreasurerForm 4 sale82,500$678k82.5%UnusualSEC
Aug 21, 2008Aug 25, 2008Orexigen Therapeutics, Inc.CFO and TreasurerForm 4 sale8,259$99k100.0%UnusualSEC
Dec 20, 2007Dec 21, 2007Orexigen Therapeutics, Inc.CFO and TreasurerForm 4 sale4,000$56k100.0%UnusualSEC
Nov 20, 2007Nov 21, 2007Orexigen Therapeutics, Inc.CFO and TreasurerForm 4 sale4,000$59k100.0%UnusualSEC